Recommended Child and Adolescent Immunization
Schedule for Ages 18 Years or Younger in 2026
Vaccines and Other Immunizing Agents in the Child and Adolescent Immunization Schedule*
Vaccine Abbreviation(s) Trade name(s)
COVID-19 vaccine 1vCOV-mRNA
Comirnaty
mNexspike
Spikevax
1vCOV-aPS Nuvaxovid
Dengue vaccine DEN4CYD Dengvaxia
Diphtheria, tetanus, and acellular pertussis vaccine DTaP Daptacel
Infanrix
Haemophilus influenzae type b vaccine Hib (PRP-T) ActHIB
Hiberix
Hib (PRP-OMP) PedvaxHIB
Hepatitis A vaccine HepA Havrix
Vaqta
Hepatitis B vaccine HepB Engerix-B
Recombivax HB
Human papillomavirus vaccine HPV Gardasil 9
Influenza vaccine (inactivated: egg-based) IIV3 Multiple
Influenza vaccine (inactivated: cell-culture) ccIIV3 Flucelvax
Influenza vaccine (recombinant) RIV3 Flublok
Influenza vaccine (live, attenuated) LAIV3 FluMist
Measles, mumps, and rubella vaccine MMR M-M-R II
Priorix
Meningococcal serogroups A, C, W, Y vaccine MenACWY-CRM Menveo
MenACWY-TT MenQuadfi
Meningococcal serogroup B vaccine MenB-4C Bexsero
MenB-FHbp Trumenba
Meningococcal serogroup A, B, C, W, Y vaccine MenACWY-TT/MenB-FHbp Penbraya
MenACWY-CRM/MenB-4C Penmenvy
Mpox vaccine Mpox Jynneos
Pneumococcal conjugate vaccine PCV15 Vaxneuvance
PCV20 Prevnar 20
Pneumococcal polysaccharide vaccine PPSV23 Pneumovax 23
Poliovirus vaccine (inactivated) IPV Ipol
Respiratory syncytial virus vaccine RSV Abrysvo
Rotavirus vaccine RV1 Rotarix
RV5 RotaTeq
Tetanus, diphtheria, and acellular pertussis vaccine Tdap Adacel
Boostrix
Tetanus and diphtheria vaccine Td Tenivac
Tdvax
Varicella vaccine VAR Varivax
Combination vaccines (use combination vaccines instead of separate injections when appropriate)
DTaP, hepatitis B, and inactivated poliovirus vaccine DTaP-HepB-IPV Pediarix
DTaP, inactivated poliovirus, and
Haemophilus influenzae type b vaccine DTaP-IPV/Hib Pentacel
DTaP and inactivated poliovirus vaccine DTaP-IPV Kinrix
Quadracel
DTaP, inactivated poliovirus, Haemophilus influenzae type b, and
hepatitis B vaccine DTaP-IPV-Hib-HepB Vaxelis
Measles, mumps, rubella, and varicella vaccine MMRV ProQuad
Monoclonal antibody Abbreviation(s) Trade name(s)
Respiratory syncytial virus monoclonal antibody RSV-mAb Beyfortus
Enflonsia
Report
• Suspected cases of reportable vaccine-preventable diseases or outbreaks to your state or local
health department
• Clinically significant adverse events to the Vaccine Adverse Event Reporting System (VAERS)
at www.vaers.hhs.gov (Accessed December 2, 2025) or 800-822-7967
• For RSV-mAb products, clinically significant adverse events to MedWatch Adverse
Event Report Program at www.accessdata.fda.gov/scripts/medwatch/index.cfm (Accessed
December 2, 2025). If co-administered with other products, then report to VAERS.
Questions or comments
Submit a question or comment to www.aap.org/en/forms/immunization-schedule-questions.
Helpful information
• Best practices for immunization (including contraindications and precautions):
www.aap.org/immunization and www.immunize.org
• Red Book: 2024–2027 Report of the Committee on Infectious Diseases (33rd Edition)
Source: AAP NEWS 10/2/2026